Kallyope is focused on innovative approaches to developing therapeutics that can address the limitations of current treatments and meet patients needs more broadly
Yes mechanistically, peptides like BPC-157 and thymosin beta-4 target tissue repair pathways (VEGF, epithelial migration) that are independent of acid suppression, so combining them with PPIs addresses both damage prevention (acid control) and mucosal healing
Wegovy (semaglutide 2.4 mg) is a glucagon-like peptide-1 receptor agonist licensed for chronic weight management in adults with obesity or overweight with weight-related comorbidities
POLISORBATOS (Emulsionantes de las vitaminas liposolubles)
A recent JAMA Psychiatry study found that nearly a third of people with eating disorders reported using a GLP-1 injection, and more than 10% had misused the drugs, raising concerns that some people are using them to fuel disordered eating
KoyaniCNKolesnikEWlkartGShresthaNScheruebelSTrummerCet al